Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)
Trial ID or NCT#
NCT03900468
Status
RECRUITING
Purpose
The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.
Official Title
Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)
Investigator(s)
Kevin Graber, MD
Epilepsy specialist,
Neurophysiologist,
Neurologist
Clinical Professor, Adult Neurology
Contact us to find out if this trial is right for you.
Contact
Jim Vollhaber
763-514-5000
View on